Ultrasound

Ultrasound, also referred to as sonography or diagnostic ultrasound, uses high-frequency sound waves to visualize soft tissue. Ultrasounds are frequently ordered to measure fetal anatomy during pregnancy, check for blood clots and to guide needle biopsy procedures of the breast, abdomen and pelvis. The imaging modality does not use any radiation to create images. Find news specific to cardiac ultrasound (echocardiography).

Internet searches reveal skyrocketing interest in POCUS implementation
New data align with a rise in intrigue around bedside point-of-care ultrasound to address growing patient demand.
Ultrasound guidance safer, more effective for biopsies of peripheral lung lesions in pediatric patients
The technique has proven effective in adults, but until recently there has been a lack of data on its use among children.
Bedside POCUS could save hospitals millions when used on patients with shortness of breath
“The explanation here is simple. Ultrasound gives you more information, and more concrete information, about what’s going on,” authors of a new JAMA study say.
3D echo guidance seeing increasing use in congenital heart surgery
Pei-Ni Jone, MD, FASE, director, echocardiography laboratory, Lurie Children’s Hospital Heart Center, member of the American Society of Echocardiography (ASE) Board, explains how 3D echo is being used to better plan, guide and follow up in congenital cardiac surgery.
GE HealthCare launches ‘ultra-premium’ Vivid Pioneer cardiovascular ultrasound system
The company describes Vivid Pioneer as its “most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet.” It includes new and improved AI capabilities and a compact design that is still fully functional in tight workspaces.

ASE establishes vocabulary for cardiac POCUS to promote consistency

As cardiac point-of-care ultrasound use continues to grow outside of traditional echo labs, the American Society of Echocardiography is working to ensure everyone is on the same page.

Hospital organization sees impressive returns from POCUS integration

“Positioned as an extension of traditional examination methods, particularly appealing to the upcoming generation of clinicians, it holds promise in potentially replacing the stethoscope in various medical assessments and procedures.”

The American Society of Echocardiography (ASE) has shared new recommendations for performing medical imaging exams on heart failure patients with surgically implanted left ventricular assist devices (LVADs) and temporary mechanical circulatory support (TMCS) devices. The guideline, published in full in the Journal of the American Society of Echocardiography, represents ASE’s first update on the topic since 2015.[1]

ASE shares new guideline on imaging patients with implanted devices

The new guideline details the best imaging strategies for a variety of clinical scenarios.

Samsung finalizes $92M acquisition of French ultrasound AI firm Sonio

Founded in 2020, the acquired firm offers products to aid physicians in assessing and documenting OB/GYN scans, such as prenatal ultrasounds.

AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.

FDA clears AI-powered POCUS platform for structural heart disease, heart failure

The cloud-based platform was designed to help even inexperienced users scan and diagnose a majority of common heart issues within minutes without leaving the patient’s side.

Ultrasound imaging startup exits ‘stealth’ mode with $4M Department of Defense contract

Maui Imaging says its product can produce images that are a "cross between ultrasound and CT" without the need for ionizing radiation.

New IR procedure for cubital tunnel syndrome

New IR procedure could be a viable alternative to surgery for cubital tunnel syndrome

The technique, which takes around 20 minutes to complete, uses ultrasound guidance to target and release Osborne's ligament with a specialized thread.

Siemens Healthineers has gained U.S. Food and Drug Administration (FDA) clearance for Acuson Origin, its new cardiovascular ultrasound system featuring advanced artificial intelligence (AI) capabilities. The Acuson Origin represents a significant update from the prior Siemens Healthineers cardiovascular ultrasound system, the Acuson SC2000.

Siemens Healthineers gains FDA clearance for new AI-powered cardiovascular ultrasound system

The Acuson Origin system includes advanced AI algorithms designed to assist users with the treatment of diagnostic, structural heart, vascular, electrophysiological and pediatric patients. It also comes packaged with a new 4D ICE catheter capable of multiplanar reconstruction imaging with or without the use of an electrocardiogram.

Ultrasound

Internet searches reveal skyrocketing interest in POCUS implementation

Ultrasound guidance safer, more effective for biopsies of peripheral lung lesions in pediatric patients

Bedside POCUS could save hospitals millions when used on patients with shortness of breath

3D echo guidance seeing increasing use in congenital heart surgery

GE HealthCare launches ‘ultra-premium’ Vivid Pioneer cardiovascular ultrasound system